ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.630,44
0,41%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4413
0,00%
Bitcoin
65.266,54
0,20%
Brent Oil
84,515
-0,32%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Starpharma Holdings Adr (QX) (SPHRY)

  7. Starpharma Holdings Adr (QX) (SPHRY) Notícias

SPHRY

Starpharma Holdings Adr (QX) (SPHRY)

Starpharma Holdings Adr (QX)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:SPHRY
DataHoraFonteTítuloCódigoCompanhia
15/09/201516:59Dow Jones NewsAustralia Looks to Health Care as Remedy for Resource-Slump DoldrumsUSOTC:SPHRYStarpharma Holdings Adr (QX)
23/10/201323:07OTC MarketsStarpharma Dendrimer-Docetaxel eliminates neutropeniaUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/10/201301:04OTC MarketsNotice of Annual General MeetingUSOTC:SPHRYStarpharma Holdings Adr (QX)
15/10/201320:45OTC MarketsReduced neurotoxicity with SPL dendrimer enhanced oxaliplatinUSOTC:SPHRYStarpharma Holdings Adr (QX)
23/09/201302:35OTC MarketsDate of Annual General MeetingUSOTC:SPHRYStarpharma Holdings Adr (QX)
19/09/201320:16OTC MarketsAppendix 3BUSOTC:SPHRYStarpharma Holdings Adr (QX)
15/09/201320:43OTC MarketsStarpharma signs Priostar Agrochemical Partnership with GowanUSOTC:SPHRYStarpharma Holdings Adr (QX)
10/09/201321:06OTC MarketsDendrimer-Oxaliplatin shows better anti-cancer efficacy and less toxicityUSOTC:SPHRYStarpharma Holdings Adr (QX)
26/08/201301:38OTC MarketsAnnual ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
19/08/201301:05OTC MarketsHome Country News ReleaseUSOTC:SPHRYStarpharma Holdings Adr (QX)
14/08/201301:00OTC MarketsHome Country News Release - Starpharma to present at Canaccord Genuity Annual Growth ConferenceUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/07/201301:00OTC MarketsHome Country News Release - Starpharma appoints Business Development executiveUSOTC:SPHRYStarpharma Holdings Adr (QX)
12/07/201301:00OTC MarketsHome Country News Release - Appendix 3BUSOTC:SPHRYStarpharma Holdings Adr (QX)
11/07/201301:00OTC MarketsHome Country News Release - ARC grant for Starpharma's targeted drug deliveryUSOTC:SPHRYStarpharma Holdings Adr (QX)
19/06/201304:08OTC MarketsNotice of Change in Substantial Holder InterestUSOTC:SPHRYStarpharma Holdings Adr (QX)
11/06/201301:00OTC MarketsHome Country News Release - Starpharma presenting at Nomura Asian Equity ForumUSOTC:SPHRYStarpharma Holdings Adr (QX)
27/05/201301:00OTC MarketsHome Country News Release - Shareholder Update: May 2013USOTC:SPHRYStarpharma Holdings Adr (QX)
22/05/201301:00OTC MarketsHome Country News Release - Corrected Form 604 - Notice of change of interests of substantial holderUSOTC:SPHRYStarpharma Holdings Adr (QX)
21/05/201301:00OTC MarketsHome Country News Release - Starpharma Boardroom Radio InterviewUSOTC:SPHRYStarpharma Holdings Adr (QX)
15/05/201301:00OTC MarketsHome Country News Release - Starpharma presenting at Goldman Sachs Emerging Companies ConferenceUSOTC:SPHRYStarpharma Holdings Adr (QX)
13/05/201301:00OTC MarketsHome Country News Release - Starpharma's dendrimer a potential viral conjunctivitis treatmentUSOTC:SPHRYStarpharma Holdings Adr (QX)
23/04/201320:35OTC MarketsQuarterly ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
17/04/201301:00OTC MarketsHome Country News Release - Starpharma Granted New Drug Delivery PatentsUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/04/201301:00OTC MarketsHome Country News Release - Change of Director's Interest NoticeUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/04/201301:00OTC MarketsHome Country News Release - Form 604 - Notice of change of interests of substantial holderUSOTC:SPHRYStarpharma Holdings Adr (QX)
03/04/201301:00OTC MarketsHome Country News Release - VivaGel study demonstrates reduced risk of recurrent BVUSOTC:SPHRYStarpharma Holdings Adr (QX)
03/04/201301:00OTC MarketsHome Country News Release - VivaGel phase 2 study results - investor conference callUSOTC:SPHRYStarpharma Holdings Adr (QX)
08/03/201301:01OTC MarketsChange of Director's Interest Notice - Richard HazletonUSOTC:SPHRYStarpharma Holdings Adr (QX)
04/03/201302:00OTC MarketsHome Country News Release - Dendrimers improve anticancer efficacy in lung metastasis modelUSOTC:SPHRYStarpharma Holdings Adr (QX)
14/02/201301:31OTC MarketsSemi-Annual ReportUSOTC:SPHRYStarpharma Holdings Adr (QX)
 Apresentando as notícias mais relevantes sobre:USOTC:SPHRY

Seu Histórico Recente

USOTC
IWTNF
Iwatani (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados